BofA Raises PT on UnitedHealth Group (UNH), Keeps a Buy Rating

​Recently, connected June 24, Bank of America Securities raised the firm's terms people connected the banal from $450 to $475, portion maintaining a Buy standing connected the shares. The steadfast noted that the affirmative sentiment is based connected BofA's increasing assurance successful outgo trends heading into Q2 earnings. BofA pointed to a higher valuation aggregate and a "continuous affirmative outlook connected trend" arsenic cardinal reasons down the move.

​That said, earlier connected June 17,  Leerink expert Whit Mayo had besides raised the terms people connected UnitedHealth from $400 to $420, portion maintaining a Buy standing connected the shares. The steadfast cited improved margins arsenic 1 of the cardinal reasons down the accrued terms target. During the archetypal quarter, the aesculapian attraction ratio improved to 83.9% from 84.8% a twelvemonth ago, outperforming expert expectations of 85.7% owed to disciplined pricing and favorable reserve development.

UnitedHealth Group Incorporated (NYSE:UNH) is simply a wellness attraction institution operating successful the United States and astir the world. The institution operates successful the UnitedHealthcare, Optum Insight, Optum Health, and Optum Rx segments.

While we admit the imaginable of UNH arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT:  10 Good Stocks to Invest successful Now and 10 Most Undervalued US Stocks According to Hedge Funds.

Disclosure: None. Follow Insider Monkey connected Google News.